{
    "clinical_study": {
        "@rank": "63590", 
        "arm_group": [
            {
                "arm_group_label": "Joalis Bambi Bronchi & Joalis Bambi Analerg", 
                "arm_group_type": "Active Comparator", 
                "description": "10 days, 2 times per day 2,5/5 ml"
            }, 
            {
                "arm_group_label": "Placebo & Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "10 days, 2 times per day 2,5/5 ml"
            }
        ], 
        "brief_summary": {
            "textblock": "Reduction of the total IgE antibody, improved vital capacity and lung volume measured by\n      spirometry.\n\n      Improving quality of life observed in the visual analogue scale (VAS)."
        }, 
        "brief_title": "Monitoring of Allergic and Asthmatic Symptoms in Patients Taking Dietary Supplements Joalis Bambi Bronchi and Joalis Bambi Analerg", 
        "condition": "Children", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  subjects with confirmed Asthma bronchiale I-III. degrees in possible combination with\n             other allergic symptoms treating with classic pharmacological treatment\n\n          -  9-18 years\n\n          -  signed Infromed Conset\n\n        Exclusion Criteria:\n\n          -  subjects who have previously used a food suplemts Joalis\n\n          -  subjects with known intolerance or hypersensitivity to the components of food\n             supplements\n\n          -  subjects with alcohol abuse or drugs at the time of recruitment into the study\n\n          -  subjects enrolled in another clinical trial in the last 1 month before enrollment in\n             this study\n\n          -  subjects in a situation which in the opinion of a doctor may interfere with optimal\n             participation in the study or can pose a risk to the subjects\n\n          -  pregnant girls, lactating girls and girls of childbearing age without adequate\n             contraception"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "9 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01684137", 
            "org_study_id": "KS-2011-05-JOALIS"
        }, 
        "intervention": [
            {
                "arm_group_label": "Joalis Bambi Bronchi & Joalis Bambi Analerg", 
                "intervention_name": "Joalis Bambi Analerg", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Joalis Bambi Bronchi & Joalis Bambi Analerg", 
                "intervention_name": "Joalis Bambi Bronchi", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo & Placebo", 
                "description": "Sugar pill manufactured to mimic Joalis Bambi Analerg", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo & Placebo", 
                "description": "Sugar pill manufactured to mimic Joalis Bambi Bronchi", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Food supplements", 
            "Asthma bronchiale"
        ], 
        "lastchanged_date": "September 10, 2012", 
        "location": {
            "contact": {
                "email": "drstickalabert@seznam.cz", 
                "last_name": "Albert Dr\u0161ti\u010dka, MUDr.", 
                "phone": "+420 577 225 992"
            }, 
            "facility": {
                "address": {
                    "city": "Zl\u00edn", 
                    "country": "Czech Republic", 
                    "zip": "760 01"
                }, 
                "name": "Alergologick\u00e1 ambulance"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Czech Republic"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "measure": "Asthma bronchiale, age 9-18 year", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_contact": {
            "email": "chroust@dscservices.cz", 
            "last_name": "Karel Chroust, RNDr., Ing., PhD..", 
            "phone": "+420 777 826 208"
        }, 
        "overall_official": {
            "affiliation": "DSC Services, s.r.o.", 
            "last_name": "Karel Chroust, RNDr., Ing., PhD.", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Czech Republic: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Reduction of the total IgE (IU/ml) antibody.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Improving of vital capacity measured by spirometry (litre).", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Improving of lung volume measured by spirometry (litre).", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01684137"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Improving of quality of life observed in the visual analogue scale (VAS).", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "DSC Services, s.r.o.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "DSC Services, s.r.o.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}